Editorial Volume 9, Issue 2 pp 301—302
Age-related mTOR in gynaecological cancers
Figure 1. Hypothetical model of mTOR-driven cancer in aged women. A potential therapeutic opportunity for the treatment of gynaecologic cancers is outlined. In post-menopausal aged women, rapamycin treatment can suppress hyperactive mTOR signalling in ovarian and uterine epithelium, potentially promoting healthy aging.